Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cancer Research|September 17, 2008
DNA vaccination controls Her-2+ tumors that are refractory to targeted therapiesPaula J Whittington, Marie P Piechocki, Henry H Heng, et al.
The Laryngoscope|September 28, 2002
In vivo characteristics of HPV-immortalized and carcinogen transformed oral keratinocytesGeorge H Yoo, Marie P Piechocki, Fulvio Lonardo, et al.
Cancer Research|January 6, 2010
Combining human and rat sequences in her-2 DNA vaccines blunts immune tolerance and drives antitumor immunityJennifer B Jacob, Elena Quaglino, Olga Radkevich-Brown, et al.
The Laryngoscope|October 29, 2004
Enhancement of Ad-p53 therapy with docetaxel in head and neck cancerGeorge H Yoo, Marie P Piechocki, Jeffery Oliver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlotGeorge H Yoo, Marie P Piechocki, John F Ensley, et al.
International Journal of Cancer|March 16, 2012
Induction of proapoptotic antibodies to triple-negative breast cancer by vaccination with TRAIL death receptor DR5 DNAMarie P Piechocki, Gen Sheng Wu, Richard F Jones, et al.
Archives of Otolaryngology--Head & Neck Surgery|July 23, 2008
Effect of docetaxel on the surgical tumor microenvironment of head and neck cancer in murine modelsGeorge H Yoo, Geetha Subramanian, Marie P Piechocki, et al.
American Journal of Otolaryngology|September 11, 2007
BMS-275183-induced gene expression patterns in head and neck carcinomaGeorge H Yoo, Vivian R Tran, Lori A Lemonnier, et al.
The Laryngoscope|December 2, 2005
Docetaxel associated pathways in cisplatin resistant head and neck squamous cell carcinoma: a pilot studyGeorge H Yoo, Ho-Sheng Lin, Andrew J Iskander, et al.
Pageof 3